Patent · US Expired

Method for the stereoselective synthesis of cyclic amino acids

US6864390B2 · kind B2 · utility

0Cited by
0References
46Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2000
Grant dateMar 8, 2005
Priority date
Expiry dateJul 8, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The instant invention is a route to stereospecific 3-substituted 5-membered ring isomers of Formula (A). The final products are useful as agents in the treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, gastrointestinal disorders such as irritable bowel syndrome (IBS), inflammation especially arthritis, sleep disorders, premenstrual syndrome, and hot flashes. The invention provides novel routes to synthesize steroselectively analogs of gabapentin (Neurontin®) of Formulas (I), (II), (III) and (IV) wherein R is C1-C10 alkyl or C3-C10 cycloalkyl and pharmaceutically acceptable salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.